Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1998
05/22/1998CA2256692A1 Saccharide derivatives
05/22/1998CA2256674A1 1-galactose derivatives
05/22/1998CA2256019A1 Solid support matrices containing a toxin binding oligosaccharide
05/22/1998CA2256016A1 1-thiogalactose derivatives
05/22/1998CA2240173A1 Thiamine disulfides and medicines containing the same as the active ingredient
05/20/1998EP0843014A2 Tryptophanyl tRNA synthetase
05/20/1998EP0842947A2 Hepatitis C virus asialoglycoproteins
05/20/1998EP0842944A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists
05/20/1998EP0842941A1 Novel phosphonates, process for their preparation and pharmaceutical compositions
05/20/1998EP0842934A1 5-HT1F agonists
05/20/1998EP0842927A1 3-Amido-chromanylsulfonyl(thio)ureas, process for their preparation, their use and medicaments containing them
05/20/1998EP0842925A1 Substituted thiazolidinedione derivatives
05/20/1998EP0842923A1 Pyrrole derivatives and medicinal composition
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842664A1 Zinc-containing compositions for oral administration including a copper compound and an aminoacid
05/20/1998EP0842663A1 Ophthalmic preparations
05/20/1998EP0842662A1 Percutaneous tape preparation containing fentanyl
05/20/1998EP0842661A2 Atherosclerosis treatment
05/20/1998EP0842660A1 Composition for treating condyloma acuminata
05/20/1998EP0842659A1 Use of estrogen agonists/antagonists for the manufacture of a medicament for the treatment of atherosclerosis
05/20/1998EP0842658A1 Photostable aqueous solution containing benzyl alcohol derivatives
05/20/1998EP0842297A1 Methods of predicting the outcome of infection
05/20/1998EP0842291A1 Inhibitors of farnesyl-protein transferase
05/20/1998EP0842290A1 Process for the preparation of lovastatin
05/20/1998EP0842284A1 Recombinant protein having bacteriophage endosialidase enzymatic activity
05/20/1998EP0842282A1 Alfa-beta c4bp-type recombinant heteromultimeric proteins
05/20/1998EP0842277A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis
05/20/1998EP0842274A1 Human mp52 arg protein
05/20/1998EP0842273A2 Receptor ligand vegf-c
05/20/1998EP0842270A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
05/20/1998EP0842269A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof
05/20/1998EP0842268A2 Methods and compositions for identifying morphogen analogs
05/20/1998EP0842266A1 Transgenic swine and swine cells having human hla genes
05/20/1998EP0842196A1 Cell adhesion inhibitors
05/20/1998EP0842193A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
05/20/1998EP0842192A2 Antimicrobial cationic peptides
05/20/1998EP0842191A2 Cyclosporin derivatives with anti-hiv activity
05/20/1998EP0842189A1 Early onset alzheimer's disease gene and gene products
05/20/1998EP0842186A1 Cross-linking oligonucleotides
05/20/1998EP0842185A1 Improved therapeutic agents
05/20/1998EP0842181A1 Membrane-permeant second messengers
05/20/1998EP0842180A1 Novel penam sulfones as beta-lactamase inhibitors
05/20/1998EP0842178A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
05/20/1998EP0842176A1 Heterocyclic compounds, their preparation and use
05/20/1998EP0842175A1 Imidazopyridine derivatives
05/20/1998EP0842174A1 Heterocyclic compounds for treating myocardial ischaemia
05/20/1998EP0842173A1 4-[3-(trans-3-dimethylaminocyclobutyl)-1h-indol-5-ylmethyl]-4(s)oxazolidin-2-one monobenzoate and sulphate salt
05/20/1998EP0842172A1 Novel substituted azacyclic or azabicyclic compounds
05/20/1998EP0842170A1 Diphenylmethylene piperidine derivatives
05/20/1998EP0842169A1 Benzothiophene compounds
05/20/1998EP0842165A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
05/20/1998EP0842164A1 Cyclic amides and derivatives thereof
05/20/1998EP0842161A1 4,5-diaryl oxazole derivatives
05/20/1998EP0842156A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
05/20/1998EP0842152A1 N-(4-substituted-benzyl)-2-aminolactam derivatives
05/20/1998EP0842151A1 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
05/20/1998EP0842150A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing said inhibitors
05/20/1998EP0842148A1 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
05/20/1998EP0842143A1 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
05/20/1998EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
05/20/1998EP0841948A1 Composition containing a nerve fibre reactivity modulating compound
05/20/1998EP0841947A1 Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
05/20/1998EP0841946A1 Methods for treatment of allergic asthma
05/20/1998EP0841945A1 Cell derived antigen presenting vesicles
05/20/1998EP0841937A1 Use of betaglycan to reduce scarring
05/20/1998EP0841933A1 Bowman-birk inhibitor compositions for treatment of imflammatory disease
05/20/1998EP0841931A1 Pharmaceutical composition
05/20/1998EP0841930A1 Stable solid formulation of enalapril salt and process for preparation thereof
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841928A1 Sustained-release formulation of d-threo-methylphenidate
05/20/1998EP0841927A1 Quinolones and their therapeutic use
05/20/1998EP0841926A1 Endothelin receptor antagonists
05/20/1998EP0841925A1 Endothelin receptor antagonists
05/20/1998EP0841924A1 Benzimidazole compounds
05/20/1998EP0841923A1 1h-4(5)-substituted imidazole derivatives
05/20/1998EP0841922A1 1h-4(5)-substituted imidazole derivatives
05/20/1998EP0841921A2 Use of fluconazole for inhibiting the growth of cancers
05/20/1998EP0841920A2 Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers
05/20/1998EP0841919A1 Inhibitors of farnesyl-protein transferase
05/20/1998EP0841917A1 Method of treatment for exercise-induced pulmonary hemorrhage in racing stock
05/20/1998EP0841916A1 Endothelin receptor antagonists
05/20/1998EP0841915A1 Use of ipriflavone to reduce the number of cd8+ cells
05/20/1998EP0841914A2 Use of griseofulvin for inhibiting the growth of cancers
05/20/1998EP0841913A1 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels
05/20/1998EP0841912A1 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substituted)hydrazines
05/20/1998EP0841911A1 Calcium-containing agent for intestinal phosphate binding and process for producing it
05/20/1998EP0841910A1 INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS
05/20/1998EP0841909A2 Use of alicyclic diamines as immunomodulators
05/20/1998EP0841908A1 1,3,3-(trisubstituted)cyclohex-1-ene dimers and related compounds
05/20/1998EP0841907A1 Use of agonists or antagonists of p 2? purinoceptors for the prevention of glutamate-evoked cytotoxicity
05/20/1998EP0841906A1 Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells
05/20/1998EP0841904A1 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
05/20/1998EP0841903A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
05/20/1998EP0841902A2 Process for preparing solid dosage forms of very low-dose drugs
05/20/1998EP0841900A1 Method of detecting lung disease
05/20/1998EP0841899A1 Compositions for topical delivery of active ingredients
05/20/1998EP0841898A1 Topical compositions having improved skin feel
05/20/1998EP0841897A1 Physically active antimicrobial gel for cosmetic products
05/20/1998EP0799032A4 Pharmacologic management of snoring
1 ... 6652 6653 6654 6655 6656 6657 6658 6659 6660 6661 6662 6663 6664 6665 6666 6667 6668 6669 6670 6671 6672 ... 7860